In this study, we leveraged scRNA-seq to dissect the cellular diversity of gene expression in tumor-infiltrating CD4+ T cells, aiming to inform precision medicine approaches for ovarian cancer treatment. This evidence concerns the gene CD4 and ovarian cancer.